CLINICAL TRIALS PROFILE FOR OMNARIS
✉ Email this page to a colleague
All Clinical Trials for OMNARIS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00458835 ↗ | Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) | Completed | AstraZeneca | Phase 4 | 2007-04-01 | The purpose of this study is to compare the systemic des-ciclesonide exposure of OMNARIS™ (ciclesonide) nasal spray, ciclesonide HFA nasal aerosol, and orally inhaled ciclesonide HFA-metered-dose inhaler (MDI). The administration of the study medication will be as follows: three single doses, separated by a wash-out period. The study will provide further data on the safety and tolerability of ciclesonide. |
| NCT01033825 ↗ | Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis | Completed | Sunovion | Phase 3 | 2010-01-01 | To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis. |
| NCT01430260 ↗ | Omnaris Versus Levocetirizine Phase 4 Study | Completed | Takeda | Phase 4 | 2011-01-01 | This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination. |
| NCT01430260 ↗ | Omnaris Versus Levocetirizine Phase 4 Study | Completed | Handok Inc. | Phase 4 | 2011-01-01 | This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OMNARIS
Condition Name
Clinical Trial Locations for OMNARIS
Trials by Country
Clinical Trial Progress for OMNARIS
Clinical Trial Phase
Clinical Trial Sponsors for OMNARIS
Sponsor Name
